[go: up one dir, main page]

MX2017002271A - Composiciones y metodos para el tratamiento de trastornos neurologicos. - Google Patents

Composiciones y metodos para el tratamiento de trastornos neurologicos.

Info

Publication number
MX2017002271A
MX2017002271A MX2017002271A MX2017002271A MX2017002271A MX 2017002271 A MX2017002271 A MX 2017002271A MX 2017002271 A MX2017002271 A MX 2017002271A MX 2017002271 A MX2017002271 A MX 2017002271A MX 2017002271 A MX2017002271 A MX 2017002271A
Authority
MX
Mexico
Prior art keywords
methods
compositions
treatment
neurological disorders
biocompatible
Prior art date
Application number
MX2017002271A
Other languages
English (en)
Inventor
A Farinelli William
GARIBYAN Lilit
Rox Anderson Richard
JAVORSKY Emilia
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of MX2017002271A publication Critical patent/MX2017002271A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434—Neural system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0293—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument interstitially inserted into the body, e.g. needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
    • A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Se describen aquí composiciones que comprenden, y métodos para emplear, suspensiones frías biocompatibles y métodos para la administración de las mismas para proporcionar una inhibición reversible de los nervios periféricos en un sujeto en necesidad del mismo.
MX2017002271A 2014-08-28 2015-08-27 Composiciones y metodos para el tratamiento de trastornos neurologicos. MX2017002271A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462042979P 2014-08-28 2014-08-28
US201562121329P 2015-02-26 2015-02-26
US201562121472P 2015-02-26 2015-02-26
PCT/US2015/047292 WO2016033380A1 (en) 2014-08-28 2015-08-27 Compositions and methods for treatment of neurological disorders

Publications (1)

Publication Number Publication Date
MX2017002271A true MX2017002271A (es) 2017-05-22

Family

ID=55400611

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2017002271A MX2017002271A (es) 2014-08-28 2015-08-27 Composiciones y metodos para el tratamiento de trastornos neurologicos.
MX2017002274A MX2017002274A (es) 2014-08-28 2015-08-27 Suspensiones inyectables y metodos de fabricacion y uso de las mismas.
MX2021007621A MX2021007621A (es) 2014-08-28 2017-02-20 Suspensiones inyectables y metodos de fabricacion y uso de las mismas.

Family Applications After (2)

Application Number Title Priority Date Filing Date
MX2017002274A MX2017002274A (es) 2014-08-28 2015-08-27 Suspensiones inyectables y metodos de fabricacion y uso de las mismas.
MX2021007621A MX2021007621A (es) 2014-08-28 2017-02-20 Suspensiones inyectables y metodos de fabricacion y uso de las mismas.

Country Status (16)

Country Link
US (7) US20170274011A1 (es)
EP (4) EP3185876B1 (es)
JP (6) JP6858698B2 (es)
KR (2) KR102507789B1 (es)
CN (4) CN117064838A (es)
AU (4) AU2015308794A1 (es)
BR (2) BR112017003111B1 (es)
CA (2) CA2958768C (es)
DK (2) DK3185876T3 (es)
ES (1) ES2898097T3 (es)
MX (3) MX2017002271A (es)
PL (1) PL3185854T3 (es)
PT (1) PT3185854T (es)
SG (4) SG10201913572TA (es)
WO (2) WO2016033384A1 (es)
ZA (3) ZA201701048B (es)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9980765B2 (en) 2010-02-15 2018-05-29 The General Hospital Corporation Methods and devices for selective disruption of visceral fat by controlled cooling
EP2640280B1 (en) 2010-11-16 2022-03-16 TVA Medical, Inc. Devices for forming a fistula
AU2012362524B2 (en) 2011-12-30 2018-12-13 Relievant Medsystems, Inc. Systems and methods for treating back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
JP2015532152A (ja) 2012-10-11 2015-11-09 ティーブイエー メディカル， インコーポレイテッド フィステル形成のための装置および方法
CA3093398C (en) 2012-11-05 2022-05-24 Relievant Medsystems, Inc. Systems and methods for creating curved paths through bone and modulating nerves within the bone
CN105228683B (zh) 2013-03-14 2022-06-10 Tva医疗公司 瘘管形成装置和用于形成瘘管的方法
WO2015085162A1 (en) 2013-12-05 2015-06-11 Rfemb Holdings, Llc Cancer immunotherapy by radiofrequency electrical membrane breakdown (rf-emb)
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
US10695534B2 (en) 2014-03-14 2020-06-30 Tva Medical, Inc. Fistula formation devices and methods therefor
US10646666B2 (en) 2014-08-27 2020-05-12 Tva Medical, Inc. Cryolipolysis devices and methods therefor
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
DK3185876T3 (da) 2014-08-28 2022-10-31 Massachusetts Gen Hospital Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
WO2016053741A1 (en) 2014-10-01 2016-04-07 Cryosa, Llc Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
US10603040B1 (en) 2015-02-09 2020-03-31 Tva Medical, Inc. Methods for treating hypertension and reducing blood pressure with formation of fistula
US11161156B2 (en) * 2015-10-27 2021-11-02 Hamilton Sundstrand Corporation Powder monitoring
WO2017124062A1 (en) 2016-01-15 2017-07-20 Tva Medical, Inc. Devices and methods for forming a fistula
CA3011238C (en) 2016-01-15 2024-01-02 Tva Medical, Inc. Devices and methods for advancing a wire
US10874422B2 (en) 2016-01-15 2020-12-29 Tva Medical, Inc. Systems and methods for increasing blood flow
US11612426B2 (en) * 2016-01-15 2023-03-28 Immunsys, Inc. Immunologic treatment of cancer
SG10201913504XA (en) 2016-02-26 2020-03-30 Massachusetts Gen Hospital Medical ice slurry production and delivery systems and methods
CN109982652B (zh) 2016-09-25 2022-08-05 Tva医疗公司 血管支架装置和方法
EP3534852B1 (en) * 2016-11-02 2022-02-02 Miraki Innovation Think Tank LLC Devices for slurry generation
US11324673B2 (en) * 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
BR112019018191A2 (pt) * 2017-03-01 2020-06-23 Miraki Innovation Think Tank Llc Crioterapias
BR112019020969A8 (pt) 2017-04-05 2022-11-16 Miraki Innovation Think Tank Llc Contenção de pasta fluida fria
BR112019020971A8 (pt) 2017-04-05 2022-11-16 Miraki Innovation Think Tank Llc Dispositivo para obter uma pasta fluida fria
US10500342B2 (en) * 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
US20210068643A1 (en) * 2017-12-11 2021-03-11 Saban Ventures Pty Limited Suspension cleaning
JP2022513342A (ja) * 2018-10-04 2022-02-07 ミラキ イノベーション シンク タンク エルエルシー スラリー及び溶液組成物
WO2020072983A1 (en) * 2018-10-04 2020-04-09 Miraki Innovation Think Tank Llc Methods of treating subcutaneous fat layers
WO2020077090A1 (en) * 2018-10-10 2020-04-16 Miraki Innovation Think Tank Llc Systems and methods of generating slurry for injection
AU2019357601A1 (en) * 2018-10-10 2021-05-13 Miraki Innovation Think Tank Llc Systems and methods for generating slurry
AU2019359364A1 (en) * 2018-10-12 2021-05-20 Miraki Innovation Think Tank Llc Cold solution for fat reduction
CN109800472B (zh) * 2018-12-26 2022-09-27 哈尔滨工程大学 一种冰桨接触过程中桨叶表面瞬时冰载压力分布计算方法
US11576812B2 (en) 2019-04-25 2023-02-14 Carlos Wambier Methods for reducing body fat in a subject
WO2021016457A1 (en) 2019-07-24 2021-01-28 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
EP4027912B1 (en) 2019-09-12 2024-12-18 Relievant Medsystems, Inc. Systems for tissue modulation
EP4034019A1 (en) 2019-09-26 2022-08-03 Miraki Innovation Think Tank LLC Miniaturized intra-body controllable medical device
BR112022012482A2 (pt) * 2019-12-24 2022-11-22 Miraki Innovation Think Tank Llc Composição, e, métodos para tratamento de tecido adiposo subcutâneo, para criar um plano de tratamento para um sujeito e para gerar uma composição
WO2021133720A1 (en) * 2019-12-26 2021-07-01 Miraki Innovative Think Tank Llc Treatment of obstructive sleep apnea
WO2021138252A1 (en) * 2019-12-31 2021-07-08 Miraki Innovative Think Tank Llc Cold solution for inducing therapeutic hypothermia
EP4093399A1 (en) * 2020-01-23 2022-11-30 The General Hospital Corporation Novel method of enhanced drug delivery to the nervous system
JP2023520775A (ja) * 2020-03-27 2023-05-19 アイクール セラピューティクス，インコーポレイテッド 医療用アイススラリーを使用して眼の表面の不快さの症状を緩和する方法
EP4178505A4 (en) 2020-07-10 2024-08-14 C° Change Surgical LLC FOOD INTAKE OF INJECTABLE MUSHROOM
US20230285350A1 (en) * 2020-07-15 2023-09-14 Lyotip, Inc. Formulations for tetracaine and lidocaine
US20220071900A1 (en) * 2020-09-08 2022-03-10 Brixton Biosciences, Inc. Systems and methods for preparing and transporting an injectable slurry
US20220087250A1 (en) * 2020-09-24 2022-03-24 Everest Medical Innovation GmbH Cryoprotective Compositions and Methods for Protection of a Surgical Site During Cryosurgery
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
EP4268150A4 (en) 2020-12-22 2024-12-18 Relievant Medsystems, Inc. PREDICTION OF CANDIDATES FOR SPINAL CORD NEUROMODULATION
US11241330B1 (en) 2021-04-02 2022-02-08 Brixton Biosciences, Inc. Apparatus for creation of injectable slurry
US11490925B1 (en) 2021-06-09 2022-11-08 Mohammed A. Alsufyani Combination ultrasound transducer and fat injecting cannula
WO2022261494A1 (en) * 2021-06-11 2022-12-15 Brixton Biosciences, Inc. Methods of creating a slurry using liposome emulsions
JP2024539656A (ja) * 2021-10-14 2024-10-29 ザ ジェネラル ホスピタル コーポレイション 閉塞性睡眠時無呼吸の処置のための組成物および方法
IL314660A (en) * 2022-02-07 2024-09-01 Martin J Moskovitz Cryosurgical device and materials and methods for its use
WO2024238743A1 (en) * 2023-05-17 2024-11-21 Edwards Lifesciences Corporation Systems for epicardial tissue distension solutions

Family Cites Families (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1256372A (en) 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US5143063A (en) 1988-02-09 1992-09-01 Fellner Donald G Method of removing adipose tissue from the body
JP2512095B2 (ja) * 1988-08-12 1996-07-03 株式会社日立製作所 冷熱発生方法
DE68916439T2 (de) 1988-10-05 1994-10-20 Vestar Inc Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
US5005364A (en) 1990-02-07 1991-04-09 Nelson William R Apparatus for and method of making and delivering slush ice
WO1993000930A1 (en) * 1991-07-05 1993-01-21 Holmes, Michael, John Improvements in or relating to contrast agents
US5507790A (en) 1994-03-21 1996-04-16 Weiss; William V. Method of non-invasive reduction of human site-specific subcutaneous fat tissue deposits by accelerated lipolysis metabolism
US5769879A (en) 1995-06-07 1998-06-23 Medical Contouring Corporation Microwave applicator and method of operation
US6126657A (en) 1996-02-23 2000-10-03 Somnus Medical Technologies, Inc. Apparatus for treatment of air way obstructions
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US6467953B1 (en) 1999-03-30 2002-10-22 Medical Solutions, Inc. Method and apparatus for monitoring temperature of intravenously delivered fluids and other medical items
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US6126684A (en) 1998-04-21 2000-10-03 The Regents Of The University Of California Indwelling heat exchange catheter and method of using same
US6546932B1 (en) 1999-04-05 2003-04-15 Cryocath Technologies Inc. Cryogenic method and apparatus for promoting angiogenesis
JP3111219B1 (ja) * 1999-05-25 2000-11-20 工業技術院長 ポリビニルアルコールを利用した冷熱輸送方法及び装置
NZ516648A (en) 1999-07-16 2004-01-30 Alza Corp A liposome composition having resistance to freeze/thaw damage
US6596333B1 (en) 1999-07-21 2003-07-22 Nestec S.A. Process for producing aerated frozen products
US6244052B1 (en) * 1999-08-02 2001-06-12 The University Of Chicago Method and apparatus for producing phase change ice particulate perfluorocarbon slurries
US6413444B1 (en) 1999-08-02 2002-07-02 The University Of Chicago Methods and apparatus for producing phase change ice particulate saline slurries
US6962601B2 (en) 1999-08-02 2005-11-08 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US7422601B2 (en) * 1999-08-02 2008-09-09 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
US7255865B2 (en) * 2000-12-05 2007-08-14 Allergan, Inc. Methods of administering botulinum toxin
US7897141B2 (en) 2002-04-01 2011-03-01 Drexel University Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
US20030032996A1 (en) * 2001-08-08 2003-02-13 Hallman Arlan Jay Cryogenic massage tube and compress
US6709431B2 (en) 2001-12-18 2004-03-23 Scimed Life Systems, Inc. Cryo-temperature monitoring
DE60332322D1 (de) * 2002-02-26 2010-06-10 Astrazeneca Ab Neue kristalline formen der krebsbekämpfenden verbindung zd1839
US8840608B2 (en) 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
CN105030324A (zh) 2002-03-15 2015-11-11 总医院公司 通过受控冷却对脂肪组织进行选择性破坏的方法和装置
US6858025B2 (en) 2002-08-06 2005-02-22 Medically Advanced Designs, Llc Cryo-surgical apparatus and method of use
US7211104B2 (en) 2002-10-08 2007-05-01 Vital Wear, Inc. Contrast therapy system and method
US7083612B2 (en) 2003-01-15 2006-08-01 Cryodynamics, Llc Cryotherapy system
US20040258760A1 (en) 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
EP1608225A4 (en) 2003-03-26 2007-07-04 Univ Minnesota HEAT METHOD AND COMPOSITIONS
US20060161232A1 (en) 2005-01-18 2006-07-20 Kasza, Oras and Son to The University of Chicago Phase-change particulate ice slurry coolant medical delivery tubing and insertion devices
US7850683B2 (en) 2005-05-20 2010-12-14 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
US7713266B2 (en) 2005-05-20 2010-05-11 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
US20090326621A1 (en) 2005-05-24 2009-12-31 Rizk El-Galley Surgical delivery devices and methods
US7389653B2 (en) * 2005-09-15 2008-06-24 The University Of Chicago Medical ice slurry production device
US20070093697A1 (en) 2005-10-21 2007-04-26 Theranova, Llc Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
GB0615287D0 (en) 2006-08-01 2006-09-06 Ares Trading Sa Integral membrane protein
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
JP2010508130A (ja) 2006-10-31 2010-03-18 ゼルティック エステティックス インコーポレイテッド 皮下高脂質細胞または皮下高脂質組織を冷却する方法およびその装置
US9254162B2 (en) 2006-12-21 2016-02-09 Myoscience, Inc. Dermal and transdermal cryogenic microprobe systems
US20080247957A1 (en) 2007-02-16 2008-10-09 Drexel University Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer
EP2195070A4 (en) 2007-05-30 2011-10-26 Critical Care Innovations Inc METHOD AND DEVICE FOR SELECTIVELY TREATING INTERSTITIAL TISSUE
US20090028797A1 (en) 2007-06-14 2009-01-29 Drexel University Novel polymeric ultrasound contrast agent and methods of making thereof
WO2009009540A1 (en) 2007-07-09 2009-01-15 Velomedix, Inc. Hypothermia devices and methods
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US9540649B2 (en) 2007-10-12 2017-01-10 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Method for opening tight junctions
US8298216B2 (en) 2007-11-14 2012-10-30 Myoscience, Inc. Pain management using cryogenic remodeling
US8563515B2 (en) 2007-11-19 2013-10-22 The Regents Of The University Of Colorado, A Body Corporate Tight junction protein modulators and uses thereof
US20090234325A1 (en) 2008-03-17 2009-09-17 Allan Rozenberg Methods and devices for non-invasive cerebral and systemic cooling
KR20100135863A (ko) 2008-04-01 2010-12-27 더 제너럴 하스피탈 코포레이션 생체조직의 냉각방법 및 냉각장치
US8505315B2 (en) * 2008-04-15 2013-08-13 Uchicago Argonne, Llc Enhanced integrated operation blender based sterile medical ice slurry production device
US7874167B2 (en) 2008-06-06 2011-01-25 C Change Surgical Llc Method and apparatus for producing slush for surgical use
WO2010017556A1 (en) 2008-08-08 2010-02-11 Palomar Medical Technologies, Inc Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue
US9060931B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8414356B2 (en) * 2008-10-31 2013-04-09 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
WO2010083281A1 (en) 2009-01-15 2010-07-22 Boston Scientific Scimed, Inc. Controlling depth of cryoablation
US8608696B1 (en) 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US20110009748A1 (en) 2009-06-11 2011-01-13 Galil Medical Ltd. Transperineal prostate biopsy system and methods
US20130011332A1 (en) 2009-09-15 2013-01-10 Searete Llc, Frozen Compositions and Methods for Piercing a Substrate
US20140200511A1 (en) * 2009-10-30 2014-07-17 Searete Llc Systems, devices, and methods for making or administering frozen particles
US9980765B2 (en) 2010-02-15 2018-05-29 The General Hospital Corporation Methods and devices for selective disruption of visceral fat by controlled cooling
AU2011293227A1 (en) 2010-08-26 2013-02-07 Cryomedix, Llc Cryoablation balloon catheter and related method
US9095320B2 (en) 2010-09-27 2015-08-04 CyroMedix, LLC Cryo-induced renal neuromodulation devices and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US9066713B2 (en) 2010-10-26 2015-06-30 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
SG191161A1 (en) 2010-12-13 2013-08-30 Myoscience Inc Method for reducing hyperdynamic facial wrinkles
GB2485864B (en) 2011-07-14 2013-05-29 Ide Technologies Ltd Vacuum ice maker (vim) with an integrated water vapor depostion process
EP3590453B1 (en) 2011-02-01 2024-02-28 Channel Medsystems, Inc. Apparatus for cryogenic treatment of a body cavity or lumen
CN103747754B (zh) 2011-06-14 2016-07-06 艾琳医药股份有限公司 用于治疗鼻气道的装置
EP2561886A1 (en) 2011-08-23 2013-02-27 Forschungsverbund Berlin e.V. Peptide adjuvant for improved peripheral analgesia
PT2768484T (pt) 2011-10-21 2019-10-28 Jazz Pharmaceuticals Res Llc Lipossomas liofilizados
CN104394813B (zh) 2011-11-16 2018-11-09 通用医疗公司 用于低温处理皮肤组织的方法和装置
CN104159534B (zh) 2012-01-13 2017-02-22 肌肉科技股份有限公司 用于美容和其他处理的皮下低温重塑的皮肤保护
EP2854681A4 (en) 2012-06-01 2016-02-17 Cibiem Inc PERCUTANEOUS METHODS AND DEVICES FOR CAROTIDE BODY ABLATION
JP6168644B2 (ja) 2012-07-12 2017-07-26 国立大学法人弘前大学 氷スラリー製造装置および氷スラリー製造方法
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9131975B2 (en) 2013-03-15 2015-09-15 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
US9023023B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US9023022B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device having release instrument
CN105208954B (zh) 2013-03-15 2019-06-04 肌肉科技股份有限公司 低温钝性解剖方法和设备
US9610112B2 (en) 2013-03-15 2017-04-04 Myoscience, Inc. Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
US9033966B2 (en) 2013-03-15 2015-05-19 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
WO2015019257A1 (en) 2013-08-05 2015-02-12 Yue Wu Method and system for producing and delivering airless medical ice slurry to induce hypothermia
US9687288B2 (en) 2013-09-30 2017-06-27 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10660688B2 (en) 2014-05-12 2020-05-26 Gary Kalser Cryotherapy device with cryoprotection and methods for performing cryotherapy with cryoprotection
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
US10646666B2 (en) 2014-08-27 2020-05-12 Tva Medical, Inc. Cryolipolysis devices and methods therefor
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
DK3185876T3 (da) 2014-08-28 2022-10-31 Massachusetts Gen Hospital Sammensætninger og fremgangsmåder til behandling af neurologiske lidelser
US9549843B2 (en) 2014-11-30 2017-01-24 C° Change Surgical Llc Production of well-mixed surgical slush
CN204468406U (zh) 2015-02-05 2015-07-15 张淑华 一种新型便携式冷敷装置
WO2016145452A1 (en) 2015-03-12 2016-09-15 Myoscience, Inc. Methods and systems for preventing neuroma formations
US20160317346A1 (en) 2015-04-28 2016-11-03 Zeltiq Aesthetics, Inc. Systems and methods for monitoring cooling of skin and tissue to identify freeze events
CA3009414A1 (en) 2016-01-07 2017-07-13 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
SG10201913504XA (en) 2016-02-26 2020-03-30 Massachusetts Gen Hospital Medical ice slurry production and delivery systems and methods
CN105640642B (zh) 2016-04-07 2018-01-12 上海导向医疗系统有限公司 带扩张球囊的内冷却微波消融针
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
DE102016115387B3 (de) 2016-08-18 2018-02-01 Cardiolectra GmbH Medizinisches Gerät zur Denervierung renaler perivaskulärer Nerven
WO2018044825A1 (en) 2016-08-30 2018-03-08 The General Hospital Corporation Cryotherapy and cryoablation systems and methods for treatment of tissue
EP3534852B1 (en) 2016-11-02 2022-02-02 Miraki Innovation Think Tank LLC Devices for slurry generation
KR101905830B1 (ko) 2016-11-15 2018-10-08 울산과학기술원 국부 냉각 마취 장치, 국부 냉각 마취 장치의 제어 방법 및 국부 냉각 마취 장치의 냉각 온도 조절기
US11324673B2 (en) 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
ES2936210T3 (es) 2017-02-04 2023-03-15 Vessi Medical Ltd Control de flujo de dispositivo de crioterapia
US9980076B1 (en) 2017-02-21 2018-05-22 At&T Intellectual Property I, L.P. Audio adjustment and profile system
BR112019018191A2 (pt) 2017-03-01 2020-06-23 Miraki Innovation Think Tank Llc Crioterapias
US20180271767A1 (en) 2017-03-21 2018-09-27 Zeltiq Aesthetics, Inc. Use of saccharides for cryoprotection and related technology
BR112019020971A8 (pt) 2017-04-05 2022-11-16 Miraki Innovation Think Tank Llc Dispositivo para obter uma pasta fluida fria
BR112019020969A8 (pt) 2017-04-05 2022-11-16 Miraki Innovation Think Tank Llc Contenção de pasta fluida fria
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
US11523855B2 (en) 2018-09-28 2022-12-13 Team Neuro LLC Spinal pain management system and method
WO2020072983A1 (en) 2018-10-04 2020-04-09 Miraki Innovation Think Tank Llc Methods of treating subcutaneous fat layers
JP2022513342A (ja) 2018-10-04 2022-02-07 ミラキ イノベーション シンク タンク エルエルシー スラリー及び溶液組成物
AU2019357601A1 (en) 2018-10-10 2021-05-13 Miraki Innovation Think Tank Llc Systems and methods for generating slurry
WO2020077090A1 (en) 2018-10-10 2020-04-16 Miraki Innovation Think Tank Llc Systems and methods of generating slurry for injection
AU2019359364A1 (en) 2018-10-12 2021-05-20 Miraki Innovation Think Tank Llc Cold solution for fat reduction
WO2021016457A1 (en) 2019-07-24 2021-01-28 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
US12121281B2 (en) 2019-08-07 2024-10-22 Christopher M. Shaari Systems and methods for cryogenic treatment of headache
US20220313484A1 (en) 2019-09-17 2022-10-06 Arrinex, Inc. Apparatus and Methods for Improved Nasal Cavity Treatments
BR112022012482A2 (pt) 2019-12-24 2022-11-22 Miraki Innovation Think Tank Llc Composição, e, métodos para tratamento de tecido adiposo subcutâneo, para criar um plano de tratamento para um sujeito e para gerar uma composição
WO2021133720A1 (en) 2019-12-26 2021-07-01 Miraki Innovative Think Tank Llc Treatment of obstructive sleep apnea
EP4093399A1 (en) 2020-01-23 2022-11-30 The General Hospital Corporation Novel method of enhanced drug delivery to the nervous system
WO2021168367A1 (en) 2020-02-19 2021-08-26 Cryosa, Inc. Systems and methods for treatment of obstructive sleep apnea
JP2023520775A (ja) 2020-03-27 2023-05-19 アイクール セラピューティクス，インコーポレイテッド 医療用アイススラリーを使用して眼の表面の不快さの症状を緩和する方法
US20210330927A1 (en) 2020-04-27 2021-10-28 Black Cat Medical Llc Method of performing cryoneurolysis
US20220071900A1 (en) 2020-09-08 2022-03-10 Brixton Biosciences, Inc. Systems and methods for preparing and transporting an injectable slurry
US20220211923A1 (en) 2020-09-24 2022-07-07 Everest Medical Innovation GmbH Cryoprotective Compositions, Surgical Kits, and Methods for Protection of a Surgical Site During Cryosurgery
US20220087250A1 (en) 2020-09-24 2022-03-24 Everest Medical Innovation GmbH Cryoprotective Compositions and Methods for Protection of a Surgical Site During Cryosurgery
US20220409428A1 (en) 2021-06-23 2022-12-29 Black Cat Medical Llc Method of performing cryoneurolysis

Also Published As

Publication number Publication date
SG10201913572TA (en) 2020-03-30
JP7201727B2 (ja) 2023-01-10
EP4176885A1 (en) 2023-05-10
JP2021098748A (ja) 2021-07-01
JP2017529336A (ja) 2017-10-05
WO2016033380A1 (en) 2016-03-03
DK3185854T3 (da) 2021-12-20
AU2015308790B2 (en) 2020-12-03
AU2021200481B2 (en) 2023-05-11
US20210244817A1 (en) 2021-08-12
ZA201701080B (en) 2019-05-29
SG10201913564WA (en) 2020-03-30
CA2958769A1 (en) 2016-03-03
US20250073336A1 (en) 2025-03-06
AU2021200481A1 (en) 2021-02-25
DK3185876T3 (da) 2022-10-31
US20170274011A1 (en) 2017-09-28
US20210236639A1 (en) 2021-08-05
CN107106481A (zh) 2017-08-29
EP3185854A1 (en) 2017-07-05
BR112017003111A2 (pt) 2017-12-05
PT3185854T (pt) 2021-12-03
US11964017B2 (en) 2024-04-23
US20170274078A1 (en) 2017-09-28
WO2016033384A1 (en) 2016-03-03
ZA201901279B (en) 2021-08-25
JP6858698B2 (ja) 2021-04-21
JP6903792B2 (ja) 2021-07-14
JP6707525B2 (ja) 2020-06-10
CN113813222A (zh) 2021-12-21
AU2015308790A1 (en) 2017-03-02
BR112017003143B1 (pt) 2023-12-05
US20250018042A1 (en) 2025-01-16
AU2015308794A1 (en) 2017-03-02
KR20170045330A (ko) 2017-04-26
EP3185854A4 (en) 2018-07-25
CN117064838A (zh) 2023-11-17
JP2020143113A (ja) 2020-09-10
CN106794138B (zh) 2021-10-01
AU2023214304A1 (en) 2023-08-31
JP2017526684A (ja) 2017-09-14
CN106794138A (zh) 2017-05-31
US11826427B2 (en) 2023-11-28
JP2021152055A (ja) 2021-09-30
SG11201701505RA (en) 2017-03-30
KR102507789B1 (ko) 2023-03-07
EP3185876A4 (en) 2018-04-18
US11938188B2 (en) 2024-03-26
EP3185854B1 (en) 2021-10-06
EP3185876A1 (en) 2017-07-05
EP3185876B1 (en) 2022-08-10
CA2958768A1 (en) 2016-03-03
BR112017003111B1 (pt) 2021-10-13
EP3988105A1 (en) 2022-04-27
ES2898097T3 (es) 2022-03-03
ZA201701048B (en) 2023-12-20
MX2021007621A (es) 2021-08-11
BR112017003143A2 (pt) 2017-11-28
SG11201701504WA (en) 2017-03-30
PL3185854T3 (pl) 2022-01-31
MX2017002274A (es) 2017-05-22
CA2958768C (en) 2023-08-29
JP2023060133A (ja) 2023-04-27
KR20170044199A (ko) 2017-04-24
US20240042034A1 (en) 2024-02-08
JP7240447B2 (ja) 2023-03-15

Similar Documents

Publication Publication Date Title
MX2017002271A (es) Composiciones y metodos para el tratamiento de trastornos neurologicos.
PH12016501809A1 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
MX2020009780A (es) Compuestos de inhibidor de autotaxina.
SI3377637T1 (sl) Sestavki za uporabo pri postopkih za zdravljenje ran, motenj in bolezni kože
TW201613919A (en) Inhibitors of Bruton's tyrosine kinase
EP3160493A4 (en) Compositions and methods to regulate renalase in the treatment of diseases and disorders
PH12016502291A1 (en) Indolizine derivatives as phosphoinositide 3-kinases inhibitors
WO2016077639A3 (en) Nanovesicular therapies
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
MX2017014456A (es) Usos terapeuticos de l-4-cloroquinurenina.
TW201613628A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
PH12016501658A1 (en) Sialylated glycoprotein compositions and uses thereof
NZ746622A (en) Use of insulin for promoting gastric emptying
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
MA40574A (fr) Traitement de maladies fibrotiques
PH12020500472A1 (en) Autotaxin inhibitor compounds
MX2017014893A (es) Composicion herbal para el tratamiento del dolor de espalda.
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci
MX2016010919A (es) 4-bencilsulfonil-2-butenonitrilo.